|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.30 EUR | -0.29% |
|
-3.49% | -1.76% |
| 03-05 | Moody's Affirms Eurofins Scientific's Ratings, Outlook on Solid Operating Performance in FY25 | MT |
| 02-17 | CIC Corporate Upgrades Eurofins Scientific to Buy Rating, Boosts PT | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | €71.71 | +16.63% | 14 | ||||||
| CHF 675.78 | +40.5% | 23 | ||||||
| US$410.92 | +44.66% | 24 | ||||||
| ₩253,958.33 | +23.58% | 24 | ||||||
| US$236.19 | +43.39% | 21 | ||||||
| US$133.37 | +40.6% | 19 | ||||||
| US$249.6 | +26.36% | 16 | ||||||
| US$489.69 | +8.72% | 13 | ||||||
| US$93.9 | +31.9% | 22 | ||||||
| €108.72 | +7.43% | 6 | ||||||
| US$77.93 | +55.92% | 14 | ||||||
| US$55.23 | +36.04% | 15 | ||||||
| US$600.71 | +104.36% | 17 | ||||||
| US$75.25 | +47.98% | 12 | ||||||
| US$197.47 | +27.02% | 15 | ||||||
| US$138.64 | +41% | 14 | ||||||
| CN¥37.92 | +36.44% | 12 | ||||||
| US$111.07 | -2.9% | 14 | ||||||
| Average | 14,317.91 | +34.98% | 16 | ||||||
| Weighted average by Cap. | 28,200.67 | +35.63% | 19 |
- Stock Market
- Equities
- ERF Stock
- Sector Eurofins Scientific SE
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition